Based on the Cardinal Health Inc stock forecast from 13 analysts, the average analyst target price for Cardinal Health Inc is USD 122.67 over the next 12 months. Cardinal Health Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Cardinal Health Inc is Bullish , which is based on 11 positive signals and 3 negative signals. At the last closing, Cardinal Health Inc’s stock price was USD 118.28. Cardinal Health Inc’s stock price has changed by +0.15% over the past week, -2.92% over the past month and +16.73% over the last year.
No recent analyst target price found for Cardinal Health Inc
No recent average analyst rating found for Cardinal Health Inc
Company Overview Cardinal Health Inc
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products, as well as medical supplies. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; offers pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression solution, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Additionally, it manufactures, prepares, delivers, and distributes radiopharmaceuticals and related treatments; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio. Read Less
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physici...Read More
Frequently Asked Questions About Cardinal Health Inc (CAH) Stock
Based on ratings from 13 analysts Cardinal Health Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 8 buy, 1 sell and 12 hold ratings.
CAH stock's dividend yield is 1.71%.
Our analysis grades CAH stock's dividend yield at A+. This means that CAH stock's dividend yield is above 100% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this CAH may be a good dividend stock for its sector.
Based on targets from 13 analysts, the average taret price for CAH is USD 122.67 over the next 12 months. The maximum analyst target price is USD 139 while the minimum anlayst target price is USD 101.
CAH stock's Price/Earning ratio is 22.75.
Our analysis grades CAH stock's Price / Earning ratio at A+. This means that CAH stock's Price/Earning ratio is above 0% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this CAH may be undervalued for its sector.
The last closing price of CAH's stock was USD 118.28.
The most recent market capitalization for CAH is USD 28.62B.
Based on targets from 13 analysts, the average taret price for CAH is projected at USD 122.67 over the next 12 months.
This means that CAH's stock price may go up by +3.71% over the next 12 months.
We can't find any ETFs which contains Cardinal Health Inc's stock.
As per our most recent records Cardinal Health Inc has 47,922 Employees.
Cardinal Health Inc's registered address is 7000 Cardinal Place, Dublin, OH, United States, 43017.
You can get more information about it from Cardinal Health Inc's website at https://www.cardinalhealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Cardinal Health Inc (CAH) Stock
Based on ratings from 13 analysts Cardinal Health Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 8 buy, 1 sell and 12 hold ratings.
CAH stock's dividend yield is 1.71%.
Our analysis grades CAH stock's dividend yield at A+. This means that CAH stock's dividend yield is above 100% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this CAH may be a good dividend stock for its sector.
Based on targets from 13 analysts, the average taret price for CAH is USD 122.67 over the next 12 months. The maximum analyst target price is USD 139 while the minimum anlayst target price is USD 101.
CAH stock's Price/Earning ratio is 22.75.
Our analysis grades CAH stock's Price / Earning ratio at A+. This means that CAH stock's Price/Earning ratio is above 0% of the stocks in the Medical Distribution sector in the NYE exchange.
Based on this CAH may be undervalued for its sector.
The last closing price of CAH's stock was USD 118.28.
The most recent market capitalization for CAH is USD 28.62B.
Based on targets from 13 analysts, the average taret price for CAH is projected at USD 122.67 over the next 12 months.
This means that CAH's stock price may go up by +3.71% over the next 12 months.
We can't find any ETFs which contains Cardinal Health Inc's stock.
As per our most recent records Cardinal Health Inc has 47,922 Employees.
Cardinal Health Inc's registered address is 7000 Cardinal Place, Dublin, OH, United States, 43017.
You can get more information about it from Cardinal Health Inc's website at https://www.cardinalhealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CAH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
